AnalystsKelsey Goodwin
Kelsey Goodwin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 23%
#1176 out of 5134 analysts
Average Return
+18.57%
Win Rate
57%12 out of 21
Risk vs Reward
Poor
Good

Kelsey Goodwin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Genelux CorpGNLX
+147.25%$3.09$7.64
2024-10-29 -
2025-10-28
Strong Buy
Revolution Medicines IncRVMD
+117.95%$36.54$79.64
2025-08-19 -
2025-12-05
Strong Buy
Urogen Pharma LtdURGN
+91.02%$12.03$22.98
2025-06-13 -
2025-12-05
Strong Buy
Cg Oncology IncCGON
+69.41%$25.56$43.30
2025-08-19 -
2025-12-05
Strong Buy
Bicara Therapeutics IncBCAX
+58.12%$11.51$18.20
2025-08-19 -
2025-12-05
Strong Buy

Kelsey Goodwin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Black Diamond Therapeutics IncBDTX
1Strong Buy$9.00+237.08%Assumes
20 days ago
Day One Biopharmaceuticals IncDAWN
1Strong Buy$26.00+228.28%Maintains
a month ago
Nuvalent IncNUVL
4Strong Buy$128.00+16.79%Maintains
a month ago
Summit Therapeutics IncSMMT
1Hold$21.00+14.69%Initiates Coverage On
4 months ago
Janux Therapeutics IncJANX
1Strong Buy$42.00+154.39%Initiates Coverage On
4 months ago
Revolution Medicines IncRVMD
1Strong Buy$75.00-5.83%Initiates Coverage On
4 months ago
Urogen Pharma LtdURGN
3Strong Buy$36.00+56.66%Initiates Coverage On
4 months ago
Cg Oncology IncCGON
1Strong Buy$55.00+27.02%Initiates Coverage On
4 months ago
Tango Therapeutics IncTNGX
1Strong Buy$11.00+14.23%Initiates Coverage On
4 months ago
Bicara Therapeutics IncBCAX
1Strong Buy$36.00+97.80%Initiates Coverage On
4 months ago
Century Therapeutics IncIPSC
2Strong Buy$5.00+850.57%Maintains
9 months ago
Genelux CorpGNLX
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
2seventy Bio IncTSVT
2Strong Buy$26.00N/AMaintains
2 years ago
Arcellx IncACLX
2Strong Buy$58.00N/AMaintains
3 years ago
Legend Biotech CorpLEGN
1HoldN/AN/AInitiates Coverage On
3 years ago
Iovance Biotherapeutics IncIOVA
1HoldN/AN/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.